Compare Centene Corp (CNC) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs US Bancorp — how do they compare? Centene Corp trades at $68.55 (market cap $33.72B), while US Bancorp trades at $62.98 (market cap $97.11B). The key difference: US Bancorp is far larger — about 2.9× Centene Corp's market cap, and US Bancorp pays a 3.34% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | USB | |
|---|---|---|
Market Cap | $33.72B | $97.11B |
Sector | Health | Financials |
52-Week High | $68.72 | $62.89 |
52-Week Low | $25.21 | $43.94 |
Enterprise Value | $26.35B | — |
Dividend Yield | — | 3.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
U.S. Bancorp (USB) trades at $62.34, near the lower end of analyst targets, with a modest daily decline. The stock shows bullish technical signals from moving averages and has consistently beaten earnings estimates in recent quarters. Revenue and net income have grown steadily, with 2025 net income reaching $7.57 billion. Recent news highlights new small business payment tools and positive earnings expectations for Q2 2026.
The outlook is supported by strong profitability and a favorable analyst consensus, but risks include elevated debt levels and interest rate sensitivity. The stock offers value with a P/E of 13.07 and a dividend, though net cash flow remains negative. Upside to the $67 consensus target depends on continued earnings execution amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
